Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Phibro Animal Health (PAHC) EBIT (2016 - 2025)

Phibro Animal Health has reported EBIT over the past 14 years, most recently at $50.3 million for Q4 2025.

  • Quarterly results put EBIT at $50.3 million for Q4 2025, up 97.1% from a year ago — trailing twelve months through Dec 2025 was $168.8 million (up 106.96% YoY), and the annual figure for FY2025 was $110.5 million, up 107.19%.
  • EBIT for Q4 2025 was $50.3 million at Phibro Animal Health, down from $51.3 million in the prior quarter.
  • Over the last five years, EBIT for PAHC hit a ceiling of $51.3 million in Q3 2025 and a floor of -$726000.0 in Q3 2023.
  • Median EBIT over the past 5 years was $19.6 million (2022), compared with a mean of $22.8 million.
  • Biggest five-year swings in EBIT: tumbled 105.31% in 2023 and later skyrocketed 2537.88% in 2024.
  • Phibro Animal Health's EBIT stood at $22.3 million in 2021, then dropped by 28.93% to $15.8 million in 2022, then fell by 0.9% to $15.7 million in 2023, then surged by 62.62% to $25.5 million in 2024, then soared by 97.1% to $50.3 million in 2025.
  • The last three reported values for EBIT were $50.3 million (Q4 2025), $51.3 million (Q3 2025), and $33.7 million (Q2 2025) per Business Quant data.